Line 237: | Line 237: | ||
<div class="row" style = "font-size:16px"> | <div class="row" style = "font-size:16px"> | ||
<div class="col-sm-12"><br> | <div class="col-sm-12"><br> | ||
+ | <p> | ||
<ul> | <ul> | ||
<li> | <li> | ||
Line 251: | Line 252: | ||
</li> | </li> | ||
+ | <br> | ||
<li>ASIJ - ASIJ_Tokyo team | <li>ASIJ - ASIJ_Tokyo team | ||
<ul> | <ul> | ||
Line 256: | Line 258: | ||
</ul> | </ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Jason Cyster - Professor at UCSF University Department of Microbiology and Immunology | <li>Dr. Jason Cyster - Professor at UCSF University Department of Microbiology and Immunology | ||
<ul> | <ul> | ||
Line 261: | Line 264: | ||
</ul> | </ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Tsu Chieh Cheng - Optomologist at Chang Cheng Eye Hospital | <li>Dr. Tsu Chieh Cheng - Optomologist at Chang Cheng Eye Hospital | ||
<ul> | <ul> | ||
Line 267: | Line 271: | ||
</ul> | </ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Wei-Chu Wu - Retina Specialist, Associate Professor at Chang Gung Memorial Hospital | <li>Dr. Wei-Chu Wu - Retina Specialist, Associate Professor at Chang Gung Memorial Hospital | ||
<ul><li>Information on current cataracts treatments and post operational complications</li></ul> | <ul><li>Information on current cataracts treatments and post operational complications</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Li Guo Min - Veterinarian at Nicholas Animal Hospital | <li>Dr. Li Guo Min - Veterinarian at Nicholas Animal Hospital | ||
<ul><li>Information on cataract development in animals and current treatments, such as the Ocluvet eye drops</li></ul> | <ul><li>Information on cataract development in animals and current treatments, such as the Ocluvet eye drops</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Jason Gestwicki - Professor at UCSF School of Medicine | <li>Dr. Jason Gestwicki - Professor at UCSF School of Medicine | ||
<ul><li>Advice on 25HC regarding protein aggression and molecular interaction</li></ul></li> | <ul><li>Advice on 25HC regarding protein aggression and molecular interaction</li></ul></li> | ||
+ | <br> | ||
<li>Dr. Eric (Ricky) P. Lee - Senior member of Technical Staff at Maxim Integrated | <li>Dr. Eric (Ricky) P. Lee - Senior member of Technical Staff at Maxim Integrated | ||
<ul><li>Assistance with troubleshooting problems encountered during nanoparticle synthesis and protein encapsulation | <ul><li>Assistance with troubleshooting problems encountered during nanoparticle synthesis and protein encapsulation | ||
Line 282: | Line 290: | ||
</ul> | </ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Mrs. Michelle Bruce - Economics Teacher at Taipei American School | <li>Mrs. Michelle Bruce - Economics Teacher at Taipei American School | ||
<ul><li>Reviewing and providing feedback on our business plan</li></ul> | <ul><li>Reviewing and providing feedback on our business plan</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Mr. Alexander kaufman - Former intern at RA Capital | <li>Mr. Alexander kaufman - Former intern at RA Capital | ||
<ul><li>Feedback on our business plan</li></ul> | <ul><li>Feedback on our business plan</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Dr. Catriona Moran and Mrs. Sharon Clapper | <li>Dr. Catriona Moran and Mrs. Sharon Clapper | ||
<ul><li>Sharing their experiences as cataracts patients and feedback on our final product</li></ul> | <ul><li>Sharing their experiences as cataracts patients and feedback on our final product</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Mission Biotech | <li>Mission Biotech | ||
<ul><li>Internal cutting sites removal for GSR and CH25H</li></ul> | <ul><li>Internal cutting sites removal for GSR and CH25H</li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Integrated DNA Technologies | <li>Integrated DNA Technologies | ||
<ul><li>CH25H gene fragment, CRYAB gene fragment, GFP full construct, CH25H full construct | <ul><li>CH25H gene fragment, CRYAB gene fragment, GFP full construct, CH25H full construct | ||
</li></ul> | </li></ul> | ||
</li> | </li> | ||
+ | <br> | ||
<li>Tri-I biotech | <li>Tri-I biotech | ||
<ul> | <ul> | ||
Line 305: | Line 319: | ||
</ul> | </ul> | ||
</li> | </li> | ||
− | <li> | + | <br> |
− | <ul><li> | + | <li>Origene |
+ | <ul><li> </li><li>cDNA for CRYAA and GSR</li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 351: | Line 366: | ||
<p>A huge thank you to our collaborators and sponsors.</p> | <p>A huge thank you to our collaborators and sponsors.</p> | ||
<br> | <br> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 18:58, 18 October 2016
Attributions
- All lab work was conducted at Taipei American School Sandy R. Puckett Memorial Research Laboratory by team members of the 2016 TAS-Taipei iGEM team, unless stated otherwise
-
National Yang Ming University - NYMU_Taipei team (click to see collaboration page)
- Consultation for troubleshooting our cloning procedure
- Ran summer camp to overview entire iGEm process from start to finish
- Ran nanoparticle calculator to give advice and troubleshoot problems and misunderstandings
- ASIJ - ASIJ_Tokyo team
- Testing our cataract treatment and prevention calculator and providing user feedback
- Dr. Jason Cyster - Professor at UCSF University Department of Microbiology and Immunology
- Advice on working with 25HC and exploring its properties in terms of cataracts treatment
- Dr. Tsu Chieh Cheng - Optomologist at Chang Cheng Eye Hospital
- Information on challenges with current drug delivery systems and cataracts surgery
- Feedback on our prototype plan
- Dr. Wei-Chu Wu - Retina Specialist, Associate Professor at Chang Gung Memorial Hospital
- Information on current cataracts treatments and post operational complications
- Dr. Li Guo Min - Veterinarian at Nicholas Animal Hospital
- Information on cataract development in animals and current treatments, such as the Ocluvet eye drops
- Dr. Jason Gestwicki - Professor at UCSF School of Medicine
- Advice on 25HC regarding protein aggression and molecular interaction
- Dr. Eric (Ricky) P. Lee - Senior member of Technical Staff at Maxim Integrated
- Assistance with troubleshooting problems encountered during nanoparticle synthesis and protein encapsulation
- Mrs. Michelle Bruce - Economics Teacher at Taipei American School
- Reviewing and providing feedback on our business plan
- Mr. Alexander kaufman - Former intern at RA Capital
- Feedback on our business plan
- Dr. Catriona Moran and Mrs. Sharon Clapper
- Sharing their experiences as cataracts patients and feedback on our final product
- Mission Biotech
- Internal cutting sites removal for GSR and CH25H
- Integrated DNA Technologies
- CH25H gene fragment, CRYAB gene fragment, GFP full construct, CH25H full construct
- Tri-I biotech
- Sequencing and primers synthesis
- Primer synthesis to remove stop codon (every gene we ordered)
- Origene
- cDNA for CRYAA and GSR
-
People involved in our bioethics panel
- Mr. Steve Anderson
- Ms. Anisha Vinod
- Dr. Nathaniel Smith
- Dr. Evonne Vidal
- Mr. Brandon Maguire
- Dr. Annemarie Costello
Some parts of this wiki have been derived from the 2014 and 2015 TAS_Taipei wiki, which was designed entirely by the 2014 and 2015 teams. All other components were designed by students of the 2016 team.
- DR. SHARON HENNESSY, TAS SUPERINTENDENT
- DR. RICHARD HARTZELL, TAS UPPER SCHOOL PRINCIPAL
- FRIENDS OF TAS
A huge thank you to our collaborators and sponsors.
![](https://static.igem.org/mediawiki/2015/b/b0/Attr_yangMing.gif)
![](https://static.igem.org/mediawiki/2015/c/c7/Attr_biobuilder.png)
![](https://static.igem.org/mediawiki/2015/f/f7/Attr_geneaid.png)
![](https://static.igem.org/mediawiki/2015/7/78/Attr_trii.jpg)
![](https://static.igem.org/mediawiki/2015/3/3e/Attr_mission.gif)
![](https://static.igem.org/mediawiki/2015/b/ba/Attr_sino.png)
![](https://static.igem.org/mediawiki/2016/e/e5/T--TAS_Taipei--Taipei_Background_1.0.jpg)
×
Zoom out to see animation.
Your screen resolution is too low unless you zoom out